MedPharm Ltd. has opened a new £0.5m GMP facility in Guildford. The investment adds a new microbiology lab, cleanroom suites, a dedicated ICH stability testing area and quality control and performance testing labs to support Phase I and II clinical manufacture. The facility also allows for the manufacture of highly potent compounds to OEB 4 level with a manufacturing batch scale of up to 50kg and primary packaging, labeling and randomization services.   Dr. Andrew Muddle, MedPharm’s chief execut...